Antonio Oliver

2.8k total citations
39 papers, 2.2k citations indexed

About

Antonio Oliver is a scholar working on Molecular Medicine, Molecular Biology and Endocrinology. According to data from OpenAlex, Antonio Oliver has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Medicine, 22 papers in Molecular Biology and 12 papers in Endocrinology. Recurrent topics in Antonio Oliver's work include Antibiotic Resistance in Bacteria (35 papers), Bacterial biofilms and quorum sensing (18 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Antonio Oliver is often cited by papers focused on Antibiotic Resistance in Bacteria (35 papers), Bacterial biofilms and quorum sensing (18 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Antonio Oliver collaborates with scholars based in Spain, Australia and Argentina. Antonio Oliver's co-authors include Carlos Juan, Bartolomé Moyá, Laura Zamorano, Gabriel Cabot, José Luis Pérez, Carmen Peña, Xavier Mulet, Fé Tubau, M.Á. Domínguez and Sebastián Albertí and has published in prestigious journals such as Nature Communications, ACS Nano and The Journal of Infectious Diseases.

In The Last Decade

Antonio Oliver

38 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Oliver Spain	24	1.8k	973	655	390	386	39	2.2k
Carla López-Causapé Spain	21	1.6k 0.9×	982 1.0×	445 0.7×	264 0.7×	281 0.7×	69	2.0k
Katy Jeannot France	29	1.9k 1.1×	1.1k 1.1×	555 0.8×	290 0.7×	486 1.3×	73	2.4k
Laura Zamorano Spain	30	2.3k 1.3×	1.2k 1.3×	935 1.4×	494 1.3×	549 1.4×	67	2.9k
Xavier Mulet Spain	22	1.6k 0.9×	890 0.9×	620 0.9×	283 0.7×	349 0.9×	34	1.9k
Gabriel Cabot Spain	33	2.6k 1.5×	1.4k 1.5×	957 1.5×	450 1.2×	523 1.4×	57	3.1k
Bartolomé Moyá Spain	32	2.7k 1.5×	1.3k 1.4×	1.1k 1.6×	586 1.5×	657 1.7×	51	3.2k
Eun-Jeong Yoon South Korea	25	1.5k 0.8×	682 0.7×	310 0.5×	341 0.9×	554 1.4×	59	2.0k
Xiaoting Hua China	31	1.7k 1.0×	876 0.9×	395 0.6×	378 1.0×	709 1.8×	138	2.6k
Alain A. Ocampo-Sosa Spain	23	1.3k 0.7×	745 0.8×	397 0.6×	263 0.7×	556 1.4×	55	2.0k
Annarita Mazzariol Italy	22	1.4k 0.8×	555 0.6×	395 0.6×	529 1.4×	598 1.5×	67	2.0k

Countries citing papers authored by Antonio Oliver

Since Specialization

Citations

This map shows the geographic impact of Antonio Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Oliver more than expected).

Fields of papers citing papers by Antonio Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Oliver. The network helps show where Antonio Oliver may publish in the future.

Co-authorship network of co-authors of Antonio Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Oliver. A scholar is included among the top collaborators of Antonio Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Oliver. Antonio Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliver, Antonio, et al.. (2025). Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa. Clinical Microbiology and Infection. 31(11). 1790–1796. 7 indexed citations

Jordana‐Lluch, Elena, Gabriel Torrens, Isabel M. Barceló, et al.. (2025). Corticosteroids modulate biofilm formation and virulence of Pseudomonas aeruginosa. Biofilm. 9. 100289–100289.

Hidalgo‐Tenorio, Carmen, et al.. (2024). The Challenge of Treating Infections Caused by Metallo‐β‐Lactamase–Producing Gram-Negative Bacteria: A Narrative Review. Drugs. 84(12). 1519–1539. 8 indexed citations

Cortés-Lara, Sara, Kate E. Rogers, Carla López-Causapé, et al.. (2024). The effects of single and multiple resistance mechanisms on bacterial response to meropenem. Clinical Microbiology and Infection. 30(10). 1276–1283. 1 indexed citations

Zamorano, Laura, et al.. (2024). Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection. 52(4). 1235–1268. 21 indexed citations

Cabot, Gabriel, et al.. (2024). Differential contribution of PBP occupancy and efflux on the effectiveness of β-lactams at their target site in clinical isolates of Neisseria gonorrhoeae. PLoS Pathogens. 20(12). e1012783–e1012783. 1 indexed citations

Caballero, Julio Diaz, Rachel M. Wheatley, Natalia Kapel, et al.. (2023). Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients. Nature Communications. 14(1). 4083–4083. 37 indexed citations

Hernández-García, Marta, María García-Castillo, Germán Bou, et al.. (2023). Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain. European Journal of Clinical Microbiology & Infectious Diseases. 43(2). 279–296. 15 indexed citations

Gomis-Font, María A., Gabriel Cabot, Irina Sánchez-Diener, et al.. (2020). In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 75(9). 2508–2515. 37 indexed citations

10.

Sánchez-Diener, Irina, Esther Viedma, Jennifer Villa, et al.. (2019). Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones. European Journal of Clinical Microbiology & Infectious Diseases. 39(4). 671–678. 21 indexed citations

11.

Gómez-Zorrilla, Sílvia, Carlos Juan, Gabriel Cabot, et al.. (2016). Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies. International Journal of Antimicrobial Agents. 47(5). 368–374. 33 indexed citations

12.

Zamorano, Laura, Irina Sánchez-Diener, Carlos Juan, et al.. (2016). Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition againstPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 72(2). 448–454. 24 indexed citations

13.

Viedma, Esther, Jennifer Villa, Carlos Juan, Antonio Oliver, & Fernando Cháves. (2014). Draft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain. Genome Announcements. 2(5). 3 indexed citations

14.

Feliziani, Sofía, Carlos Juan, Blanca Gatti, et al.. (2014). Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. International Journal of Medical Microbiology. 304(8). 1182–1191. 31 indexed citations

15.

Suárez, Cristina, Carmen Peña, M.Á. Domínguez, et al.. (2011). A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition. BMC Infectious Diseases. 11(1). 272–272. 51 indexed citations

16.

Zamorano, Laura, Carlos Juan, Bartolomé Moyá, et al.. (2011). AmpG Inactivation Restores Susceptibility of Pan-β-Lactam-Resistant Pseudomonas aeruginosa Clinical Strains. Antimicrobial Agents and Chemotherapy. 55(5). 1990–1996. 48 indexed citations

17.

Moyá, Bartolomé, Laura Zamorano, Carlos Juan, Yigong Ge, & Antonio Oliver. (2010). Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins ofPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 54(9). 3933–3937. 92 indexed citations

18.

Juan, Carlos, Laura Zamorano, José Luis Pérez, Yigong Ge, & Antonio Oliver. (2009). Activity of a New Antipseudomonal Cephalosporin, CXA-101 (FR264205), against Carbapenem-Resistant and Multidrug-Resistant Pseudomonas aeruginosa Clinical Strains. Antimicrobial Agents and Chemotherapy. 54(2). 846–851. 80 indexed citations

19.

Juan, Carlos, Bartolomé Moyá, José Luis Pérez, & Antonio Oliver. (2006). Stepwise Upregulation of thePseudomonas aeruginosaChromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD Homologues. Antimicrobial Agents and Chemotherapy. 50(5). 1780–1787. 136 indexed citations

20.

Macià, María D., et al.. (2005). Caracterización molecular de un brote por Enterococcus faecalis resistente a los glucopéptidos en una unidad de cuidados intensivos. Enfermedades Infecciosas y Microbiología Clínica. 23(8). 460–463. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact